ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Perfusion Regulated Organ Therapeutics with Enhanced Controlled Testing (PROTECT): Novel Human Model to Mitigate Ischemia-Reperfusion Injury in Liver Transplant

    M. Nazzal, E. Madsen, M. Nguyen, A. Welu, H. Madnawat, C. Manithody, C. Denton, D. Blackall, D. Carpenter, J. Teckman, C. Varma, A. Jain

    Saint Louis University, Saint Louis, MO

    *Purpose: Despite a global organ shortage, there is almost a 10% discard rate of ‘marginal donor livers’ (MDL), deemed unsuitable for transplantation due to the…
  • 2020 American Transplant Congress

    Blocking Complement Component C3 in a Sensitized Nonhuman Primate Model of Kidney Allotransplantation

    R. Schmitz1, P. M. Schroder1, Z. W. Fitch1, A. Y. Choi1, M. Manook1, J. Yoon1, A. Farris2, E. S. Reis3, J. D. Lambris3, J. Kwun1, S. J. Knechtle1

    1Department of Surgery, Duke University Medical Center, Durham, NC, 2Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, 3Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

    *Purpose: Sensitized transplant recipients represent a challenge due to the presence of donor-specific antibodies (DSA), which increase the risk of antibody-mediated rejection. Complement inhibition has…
  • 2020 American Transplant Congress

    Introduction of Preemptive Pharmacogenomic Testing in Kidney Transplant Recipients: Early Evaluation of the Clinical Impact of Genomic Guided Tacrolimus Dosing

    G. Girone1, V. Do1, K. Belfield1, R. Pulk1, E. Cohen1, E. Marin2

    1Department of Pharmacy, Yale New Haven Hospital, New Haven, CT, 2Department of Nephrology, Yale School of Medicine, New Haven, CT

    *Purpose: Tacrolimus is widely accepted as the mainstay of immunosuppression in solid organ transplant. Inherited differences in CYP3A activity are known to contribute to dosing…
  • 2020 American Transplant Congress

    Recurrence of IgA Nephropathy after Kidney Transplantation – Tango Multicenter Study

    A. Uffing1, P. Cravedi2, L. V. Riella1

    1Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Icahn School of Medicine at Mount Sinai, New York, NY

    *Purpose: In patients with IgA nephropathy as the cause of ESKD, IgA deposits can recur in the transplanted kidney. However,the incidence and clinical impact of…
  • 2020 American Transplant Congress

    The Impact of Pre-Existing and New Onset Diabetes on Healthcare Utilization Following Kidney Transplantation

    D. Taber, N. Pilch, N. Patel, H. Perkins, K. Foster, C. Perez, F. Bartlett, A. Posadas, H. Meadows, K. Soliman, V. Rao, M. Casey, V. Rohan, J. McGillicuddy, S. Nadig, D. Dubay

    MUSC, Charleston, SC

    *Purpose: Diabetes (DM) represents a global epidemic; it is the leading cause of ESRD in the US and a predominant etiology for kidney transplantation (KTX).…
  • 2020 American Transplant Congress

    Impact of Allograft Nephrectomy on Outcomes in Second Kidney Transplantation

    N. Sato, Y. Kakuta, T. Kanzawa, K. Unagami, M. Okumi, H. Ishida, K. Tanabe

    Urology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan

    *Purpose: The impact of failed allograft nephrectomy on the outcome of second kidney transplantation is not clear. We evaluated the effects of the first allograft…
  • 2020 American Transplant Congress

    Technology Access, Use, and Intent among Kidney Transplant Candidates Vulnerable to Health Disparities

    S. Smith1, M. Keller2, R. Seibert3, L. Kayler1

    1Transplant, Transplant and Kidney Care Regional Center of Excellence, Erie County Medical Center, Buffalo, NY, 2Transplant, University at Buffalo, State University of New York, Department of Community Health and Health Behavior, Buffalo, NY, 3Transplant, University at Buffalo, State University of New York, Department of Epidemiology and Environmental Health, Buffalo, NY

    *Purpose: Advances in eHealth have created opportunities to reach vulnerable populations, however, eHealth strategies could paradoxically increase health disparities if vulnerable individuals lack technology access…
  • 2020 American Transplant Congress

    Successful Transplantation of the Kidney Graft with 5 Arteries and Intimal Dissection Injury – 9 Year Follow Up

    P. J. Bachul1, A. Perez-Gutierrez1, R. Saoud1, B. Juengel1, D. J. Grybowski1, P. Borek1, R. Anteby2, A. Lucander1, M. Dimitrov1, J. Fung1, P. Witkowski1

    1Surgery, University of Chicago, Chicago, IL, 2Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    *Purpose: Utilization of the Carrel patch allows easier implantation of the kidney graft with multiple small renal arteries. If it is not feasible, side-to-side renal…
  • 2020 American Transplant Congress

    Outcomes of Post-Transplant Desensitization in High Immunological Risk Deceased Donor Kidney Transplant Recipients

    D. Kumar, C. Song, L. Kamal, I. Moinuddin, M. Levy, C. Bhati, A. King, P. Kimball, G. Gupta

    Virginia Commonwealth University, Richmond, VA

    *Purpose: The kidney allocation system (KAS) was changed in 2015 to increase access to transplants for highly sensitized patients. However, recent data suggests that even…
  • 2020 American Transplant Congress

    A Single-Center Experience in Transfusion-Free Liver Transplantation: Referrals and Outcomes from 2005 to 2019

    B. H. Horwich1, A. Mulgaonkar1, B. Kim2, N. Kaur1, J. Kahn2, Y. Genyk3, A. Ahearn3, H. Han2

    1Internal Medicine, University of Southern California, Los Angeles, CA, 2GI & Liver Diseases, University of Southern California, Los Angeles, CA, 3Surgery, University of Southern California, Los Angeles, CA

    *Purpose: The Jehovah’s Witnesses is a religious group known to the medical community for its non-acceptance of blood products. This poses a significant challenge in…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences